JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 25, 2004; DOI: 10.1124/jpet.104.068031


0022-3565/04/3111-123-130$20.00
JPET 311:123-130, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.068031v1
311/1/123    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ye, Y. N.
Right arrow Articles by Cho, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ye, Y. N.
Right arrow Articles by Cho, C. H.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

The Modulating Role of Nuclear Factor-{kappa}B in the Action of {alpha}7-Nicotinic Acetylcholine Receptor and Cross-Talk between 5-Lipoxygenase and Cyclooxygenase-2 in Colon Cancer Growth Induced by 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone

Yi N. Ye, Edgar S. L. Liu, Vivian Y. Shin, William K. K. Wu, and Chi H. Cho

Department of Pharmacology, Faculty of Medicine, Zhejiang University, China (Y.N.Y.); and Department of Pharmacology, Faculty of Medicine, The University of Hong Kong, China (Y.N.Y., E.S.L.L., V.Y.S., W.K.K.W., C.H.C.)

4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), the tobacco-specific nitrosamine, induces lung cancer in all animal species tested and is thought to contribute significantly to the high lung cancer burden associated with smoking. However, there is no report whether NNK could promote colon cancer growth. To address this hypothesis and the possible signaling pathways involved, we used SW1116 colon cancer cell line to study these biological events in vitro. Results showed that NNK, after 5-h treatment, stimulated cell proliferation, enhanced {alpha}7-nicotinic acetylcholine receptor ({alpha}7-nAChR) mRNA levels and nuclear factor-{kappa}B (NF-{kappa}B) DNA binding activity, as well as 5-lipoxygenase and cyclooxygenase-2 protein expressions. {alpha}-Bungarotoxin, the specific {alpha}7-nAChR antagonist, inhibited these biological effects. However, 5-lipoxygenase inhibition had no effect on {alpha}7-nAChR mRNA expression, but significantly inhibited cell proliferation and activation of NF-{kappa}B and cyclooxygenase-2, whereas NF-{kappa}B-specific inhibitor caffeic acid phenethyl ester reduced both cell proliferation and cyclooxygenase expression induced by NNK without affecting {alpha}7-nAChR mRNA level and 5-lipoxygenase expression. Together, the present study demonstrated that NNK promoted colon cancer growth in vitro. NF-{kappa}B not only conveys the biological effect of {alpha}7-nAChR activation but is also involved in the cross-talk between 5-lipoxygenase and cyclooxygenase-2 in response to NNK in colon cancer cell development.


Received March 8, 2004; accepted May 25, 2004.

Address correspondence to: Prof. C. H. Cho, Department of Pharmacology, Faculty of Medicine, The University of Hong Kong, 1/F Li Shu Fan Bldg., 5 Sassoon Rd., Hong Kong, China. E-mail: chcho{at}hkusua.hku.hk




This article has been cited by other articles:


Home page
Toxicol SciHome page
S. W. Chung, A. Toriba, H. Y. Chung, B. P. Yu, T. Kameda, N. Tang, R. Kizu, and K. Hayakawa
Activation of 5-Lipoxygenase and NF-{kappa}B in the Action of Acenaphthenequinone by Modulation of Oxidative Stress
Toxicol. Sci., January 1, 2008; 101(1): 152 - 158.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. P. S. Wong, L. Yu, E. K. Y. Lam, E. K. K. Tai, W. K. K. Wu, and C.-H. Cho
Nicotine Promotes Colon Tumor Growth and Angiogenesis through {beta}-Adrenergic Activation
Toxicol. Sci., June 1, 2007; 97(2): 279 - 287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. A. Jaimes, R.-X. Tian, and L. Raij
Nicotine: the link between cigarette smoking and the progression of renal injury?
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H76 - H82.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. Arredondo, A. I. Chernyavsky, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando
Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of {alpha}7 nicotinic receptor in oral keratinocytes
FASEB J, October 1, 2006; 20(12): 2093 - 2101.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. K.K. Wu, H. P.S. Wong, S. W. Luo, K. Chan, F. Y. Huang, M. K.C. Hui, E. K.Y. Lam, V. Y. Shin, Y. N. Ye, Y. H. Yang, et al.
4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone from Cigarette Smoke Stimulates Colon Cancer Growth via {beta}-Adrenoceptors
Cancer Res., June 15, 2005; 65(12): 5272 - 5277.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. R. Hirsch and S. M. Lippman
Advances in the Biology of Lung Cancer Chemoprevention
J. Clin. Oncol., May 10, 2005; 23(14): 3186 - 3197.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.